Department of Biomedical Engineering, Wisconsin Institutes for Medical Research, University of Wisconsin-Madison, 1111 Highland Avenue, Madison, Wisconsin, 53705, United States.
Medical Engineering, Morgridge Institute for Research, 330 N Orchard street, Madison, WI, 53715, USA.
Sci Rep. 2019 Apr 17;9(1):6199. doi: 10.1038/s41598-019-42529-8.
The tumour microenvironment (TME) has recently drawn much attention due to its profound impact on tumour development, drug resistance and patient outcome. There is an increasing interest in new therapies that target the TME. Nonetheless, most established in vitro models fail to include essential cues of the TME. Microfluidics can be used to reproduce the TME in vitro and hence provide valuable insight on tumour evolution and drug sensitivity. However, microfluidics remains far from well-established mainstream molecular and cell biology methods. Therefore, we have developed a quick and straightforward collagenase-based enzymatic method to recover cells embedded in a 3D hydrogel in a microfluidic device with no impact on cell viability. We demonstrate the validity of this method on two different cell lines in a TME microfluidic model. Cells were successfully retrieved with high viability, and we characterised the different cell death mechanisms via AMNIS image cytometry in our model.
肿瘤微环境(TME)因其对肿瘤发展、耐药性和患者预后的深远影响而受到越来越多的关注。人们对靶向 TME 的新疗法越来越感兴趣。然而,大多数已建立的体外模型未能包含 TME 的基本线索。微流控技术可用于在体外重现 TME,从而为肿瘤进化和药物敏感性提供有价值的见解。然而,微流控技术远未成为主流的分子和细胞生物学方法。因此,我们开发了一种快速而简单的基于胶原酶的酶法,可在微流控装置中从嵌入 3D 水凝胶的细胞中回收细胞,而不会对细胞活力产生影响。我们在 TME 微流控模型中用两种不同的细胞系证明了这种方法的有效性。细胞以高活力成功回收,并且我们通过我们模型中的 AMNIS 图像细胞术对不同的细胞死亡机制进行了表征。